✦ LIBER ✦

Can we do better in developing new drugs for Alzheimer's disease?

✍ Scribed by Serge Gauthier; Philip Scheltens

Book ID: 118465720
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 160 KB
Volume: 5
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2009.09.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug development for Alzheimer's disease

Drug development for Alzheimer's disease: Where are we now and where are we headed?

✍ Marwan N. Sabbagh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Editorial: New drugs for Alzheimer's dis

Editorial: New drugs for Alzheimer's disease in Japan

✍ Masatoshi Takeda; Toshihisa Tanaka; Masayasu Okochi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

Can herbs provide a new generation of dr

Can herbs provide a new generation of drugs for treating Alzheimer's disease?

✍ Thimmappa S. Anekonda; P. Hemachandra Reddy 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Global issues in drug development for Al

Global issues in drug development for Alzheimer’s disease

✍ Rachelle S. Doody; Patricia E. Cole; David S. Miller; Eric Siemers; Ronald Black 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 459 KB

Progress in the development of new drugs

Progress in the development of new drugs in Alzheimer’s disease

✍ Antoine Piau; F. Nourhashémi; C. Hein; C. Caillaud; B. Vellas 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 188 KB

Cholinergic abnormalities in Alzheimer's

Cholinergic abnormalities in Alzheimer's disease: are there new targets for drug development?

✍ Lisa R. Fodero; David H. Small 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

## Abstract Alzheimer's disease (AD) is a neurodegenerative disease characterized by cognitive impairment and behavioral changes. Cholinesterase inhibitors are currently the drugs of choice for the treatment of AD. However, alternatives to cholinesterase inhibitors such as muscarinic and nicotinic